Trial intelligence / Profile preview

Volume Dependent Effect of PENG Block in Femur Fracture

NCT05256056Completed

Sponsor
Şişli Hamidiye Etfal Training and Research Hospital
Start
Feb 2022
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Şişli Hamidiye Etfal Training and Research Hospital. Primary endpoint: Visual Analogue Scale up to 24 hours. Started Feb 2022; status: completed.

02

Drugs

bupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05256056.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05256056.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call